Bought
Maintained
Sold
Other funds holding PATH
TAM
SM
Nuveen's PATH Position: Q2 2026 in Review
Nuveen increased its UiPath (PATH) stake by 17% in Q2 2026, buying an estimated $1.88M and bringing the position to 1,183,409 shares worth $12.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1536.
Nuveen first reported a position in PATH in Q2 2021 and has held it in 20 quarters since. The position peaked at $167M in Q2 2021. 528 funds tracked by Wall St. Rank hold PATH as of Q2 2026.
- Nuveen held 1,183,409 shares of UiPath worth $12.9M as of Q2 2026.
- Nuveen bought 176,006 UiPath shares in Q2 2026, an estimated $1.88M.
- UiPath made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #1536 holding.
- Nuveen first reported a position in UiPath in Q2 2021 and has held it in 20 quarters since.
- Nuveen's UiPath position peaked at $167M in Q2 2021.
- 528 funds tracked by Wall St. Rank held UiPath as of Q2 2026.
Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.